Markets:

Overview

News

Currencies

International

Treasuries

KALA BIO, Inc. - Common Stock (NQ:KALA)

0.3800 -0.0242 (-5.99%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about KALA BIO, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Nasdaq Jumps 150 Points; US Pending Home Sales Rise ↗

September 29, 2025

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 150 points on Monday. Following the market opening Monday, the Dow traded up 0.19% to 46,333.68 while the NASDAQ rose...

Via Benzinga

Topics Stocks

Kala Bio Stock Just Plunged 92% Today – Here’s What Happened ↗

September 29, 2025

The firm stated that its KPI-012 failed in a mid-stage clinical trial and announced that it intends to preserve cash, including by laying off some of its workforce and deploying other cost-saving...

Via Stocktwits

Topics Workforce

5 Healthcare Stocks On Fire This Week ↗

August 21, 2025

Healthcare stocks SNOA, EVOK, KALA, DNA, & SNGX soar with massive momentum gains, signaling breakout potential in biotech & pharma.

Via Benzinga

Kala Bio (KALA) Q2 Loss Widens 15% ↗

August 08, 2025

Via The Motley Fool

KALA Stock Earnings: Kala Bio Beats EPS for Q2 2024 ↗

August 06, 2024

KALA stock results show that Kala Bio beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Kala Bio: Q3 Earnings Insights ↗

November 13, 2023

Via Benzinga

Kala Pharmaceuticals: Q1 Earnings Insights ↗

May 09, 2023

Kala Pharmaceuticals (NASDAQ:KALA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Where Kala Pharmaceuticals Stands With Analysts ↗

May 01, 2023

Via Benzinga

This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday ↗

July 11, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 29, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 22, 2025

Via Benzinga

Kala Bio Stock Sinks On CEO Exit, But Retail Feels It’s An Overreaction ↗

February 12, 2025

Kala is set to report mid-stage trial data in the second quarter for KPI-012, its experimental treatment for persistent corneal epithelial defects.

Via Stocktwits

Peering Into Kala Pharmaceuticals's Recent Short Interest ↗

March 08, 2023

Via Benzinga

Dow Drops More Than 400 Points After CPI Data ↗

February 12, 2025

This morning's hotter-than-expected CPI data sent the market reeling, after the annual inflation rate rose to 3% and the 12-month core inflation rate rose to 3.3%.

Via Talk Markets

Topics Economy Stocks Stocks / Equities

KALA Stock Earnings: Kala Pharmaceuticals Misses EPS for Q1 2024 ↗

May 14, 2024

KALA stock results show that Kala Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

KALA Stock Earnings: Kala Pharmaceuticals Beats EPS for Q4 2023 ↗

April 02, 2024

KALA stock results show that Kala Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 05, 2023

Via Benzinga

10 Short Squeeze Stocks To Watch: Aeglea Biotherapeutics, Toro Corp, AirSculpt, A Company Moves Up 4,166 Positions & More ↗

July 24, 2023

Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 02, 2023

Via Benzinga

10 Short Squeeze Stocks To Watch: Toro Corp, PaxMedica, Getty Images And More ↗

May 15, 2023

Potential short squeeze plays gained steam in 2021, continued through 2022, and remain a focus of new traders looking for the next huge move. High-short interest and high-cost to borrow are among the...

Via Benzinga

5 Short Squeeze Stocks To Watch: Getty Images, Bullfrog AI And A New Leader For The Week ↗

May 08, 2023

Potential short squeeze plays gained steam in 2021, continued through 2022, and remain a focus of new traders looking for the next huge move. High short interest and high cost to borrow are among the...

Via Benzinga

10 Short Squeeze Stocks To Watch: Getty Images, Guardforce AI And 2 Stocks Moving Up Over 1,000 Positions On The Leaderboard ↗

April 24, 2023

Via Benzinga

5 Short Squeeze Stocks To Watch: Getty Images, PaxMedica, A Mental Health Care Company And More ↗

April 17, 2023

Via Benzinga

Short Interest Sector Focus: Healthcare Sector ↗

April 04, 2023

As of the close of business on Monday, 3/31, we captured the Top 10 Highest Short Interest % stocks within the Healthcare sector. The average short interest for stocks within the Healthcare sector...

Via Benzinga

5 Short Squeeze Stocks To Watch: Unicycle Therapeutics, Getty Images And More ↗

April 03, 2023

Potential short squeeze plays gained steam in 2021 and continued through 2022 with new traders looking for the next huge move. High short interest and high cost to borrow are among the common traits...

Via Benzinga

10 Short Squeeze Candidates: Unicycle Therapeutics, Compass Pathways, Virgin Orbit Among Those To Watch ↗

March 27, 2023

Potential short squeeze plays gained steam in 2021 and continued through 2022 with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits...

Via Benzinga

Kala Pharma Reveals Safety Data From Stem Cell Therapy Trial For Corneal Defect Impacting Around 240K People In Developed Nations ↗

March 27, 2023

Via Benzinga

10 Short Squeeze Candidates: PaxMedica, Blue Apron, MicroStrategy And More ↗

March 20, 2023

Via Benzinga

5 Short Squeeze Candidates To Watch: Ambrx Biopharma, Kala Pharmaceuticals And This Company That Moved Up 1,403 Positions ↗

March 13, 2023

Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 08, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

KALA BIO, Inc. - Common Stock (NQ:KALA)

Headline News about KALA BIO, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today